Invex Therapeutics Ltd.'s market cap is currently AU$5.64M. The company's EPS TTM is AU$0.001; its P/E ratio is 43.33; Invex Therapeutics Ltd. is scheduled to report earnings on February 13, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 24	Jun 23	Jun 22	Jun 21	Jun 20
Income Statement
Total Revenue	AU$ 1.21M	AU$ 459.08K	AU$ 182.25K	AU$ 0.00	AU$ 0.00
Gross Profit	AU$ 1.21M	AU$ 459.08K	AU$ 182.25K	AU$ 0.00	AU$ 0.00
Operating Income	AU$ -2.13M	AU$ -8.55M	AU$ -4.03M	AU$ -2.44M	AU$ -3.29M
EBITDA	AU$ -720.44K	AU$ 0.00	AU$ 0.00	AU$ 0.00	AU$ 0.00
Net Income	AU$ -1.64M	AU$ -7.75M	AU$ -3.95M	AU$ -2.28M	AU$ -3.36M
Balance Sheet
Cash & Short-Term Investments	AU$ 6.03M	AU$ 22.47M	AU$ 29.34M	AU$ 32.72M	AU$ 26.30M
Total Assets	AU$ 6.12M	AU$ 22.80M	AU$ 29.49M	AU$ 32.74M	AU$ 26.42M
Total Debt	AU$ 0.00	AU$ 0.00	AU$ 0.00	AU$ 0.00	AU$ 0.00
Net Debt	AU$ -6.03M	AU$ -22.47M	AU$ -29.34M	AU$ -32.72M	AU$ -26.30M
Total Liabilities	AU$ 431.63K	AU$ 1.57M	AU$ 1.00M	AU$ 658.61K	AU$ 2.02M
Stockholders' Equity	AU$ 5.69M	AU$ 21.23M	AU$ 28.48M	AU$ 32.08M	AU$ 24.40M
Cash Flow
Free Cash Flow	AU$ -2.44M	AU$ -6.87M	AU$ -3.38M	AU$ -1.68M	AU$ -1.60M
Operating Cash Flow	AU$ -2.44M	AU$ -6.87M	AU$ -3.38M	AU$ -1.68M	AU$ -1.60M
Investing Cash Flow	AU$ 0.00	AU$ 0.00	AU$ 0.00	AU$ 0.00	AU$ 0.00
Financing Cash Flow	AU$ -14.00M	AU$ 0.00	AU$ 0.00	AU$ 8.09M	AU$ 15.73M

Currency in AUD

Invex Therapeutics Ltd. Earnings and Revenue History

Income Statement >

Invex Therapeutics Ltd. Debt to Assets

Balance Sheet >

Invex Therapeutics Ltd. Cash Flow

Cash Flow >

Invex Therapeutics Ltd. Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing